1. Home
  2. EMBC vs CFFN Comparison

EMBC vs CFFN Comparison

Compare EMBC & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • CFFN
  • Stock Information
  • Founded
  • EMBC 1924
  • CFFN 1893
  • Country
  • EMBC United States
  • CFFN United States
  • Employees
  • EMBC N/A
  • CFFN N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • CFFN Savings Institutions
  • Sector
  • EMBC Health Care
  • CFFN Finance
  • Exchange
  • EMBC Nasdaq
  • CFFN Nasdaq
  • Market Cap
  • EMBC 788.4M
  • CFFN 813.3M
  • IPO Year
  • EMBC N/A
  • CFFN 1999
  • Fundamental
  • Price
  • EMBC $14.38
  • CFFN $6.42
  • Analyst Decision
  • EMBC Buy
  • CFFN Hold
  • Analyst Count
  • EMBC 2
  • CFFN 1
  • Target Price
  • EMBC $19.00
  • CFFN $6.50
  • AVG Volume (30 Days)
  • EMBC 741.6K
  • CFFN 653.1K
  • Earning Date
  • EMBC 08-08-2025
  • CFFN 10-22-2025
  • Dividend Yield
  • EMBC 4.17%
  • CFFN 5.33%
  • EPS Growth
  • EMBC 18.26
  • CFFN N/A
  • EPS
  • EMBC 1.42
  • CFFN 0.47
  • Revenue
  • EMBC $1,102,500,000.00
  • CFFN $192,483,000.00
  • Revenue This Year
  • EMBC N/A
  • CFFN $10.56
  • Revenue Next Year
  • EMBC N/A
  • CFFN $11.73
  • P/E Ratio
  • EMBC $10.12
  • CFFN $13.57
  • Revenue Growth
  • EMBC N/A
  • CFFN N/A
  • 52 Week Low
  • EMBC $9.20
  • CFFN $4.90
  • 52 Week High
  • EMBC $21.48
  • CFFN $7.20
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 73.57
  • CFFN 65.50
  • Support Level
  • EMBC $13.35
  • CFFN $6.02
  • Resistance Level
  • EMBC $14.09
  • CFFN $6.20
  • Average True Range (ATR)
  • EMBC 0.61
  • CFFN 0.12
  • MACD
  • EMBC 0.21
  • CFFN 0.04
  • Stochastic Oscillator
  • EMBC 91.40
  • CFFN 97.93

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

Share on Social Networks: